Series A · Biotech · Copenhagen, Denmark · Founded 2018 · 25–35 employees
Octarine Bio is a synthetic biology company that develops bio-based sustainable dyes and pigments through precision fermentation to replace harmful synthetic chemicals in the textile industry. Their PurePalette platform offers 91% lower CO2 emissions, 47% lower human toxicity, and 94% lower energy usage compared to traditional dye manufacturing. The company has raised €12.8M in Series A funding led by notable investors including DSM-Firmenich Ventures and The Footprint Firm. Founded in 2018 and spun out from University of Copenhagen research, they also develop cannabinoids and psilocybin derivatives for pharmaceutical applications.
No open roles listed right now.